SpringFire Laboratory Network has named Gregory Stelzer, Ph.D., scientific director. Stelzer’s responsibilities include development and implementation of corporate and scientific strategies in addition to management of the scientific team.

Most recently, Stelzer served as senior vice president of advanced development at Nodality. Prior to that, he held positions as chief science officer at Exagen Diagnostics, Esoterix Laboratory and Cytometry Associates.

“In clinical laboratories and particularly flow cytometry, Greg Stelzer is among the top in the world,” said Jim McClintic, managing partner of SpringFire Laboratory Network. “Dr. Stelzer brings significant experience in clinical trials, particularly cell analysis, to SpringFire, and we are very excited to have him join our team.”